Correlative study between neuron-specific enolase and blood sugar level in ischemic stroke patients

Journal of Neurosciences in Rural Practice

Volumn 2, Issue 1, 2011, Pages 50-54

  Pandey, Aparna ^a   Saxena, Kiran ^b   Verma, Meena ^a   Bharosay, Anuradha ^a  

^a Aurobindo Hospital   (India)

^b Department of Biochemistry   (India)

Author keywords

Hyperglycemia; Ischemic Stroke; lipid profile; neuron specific enolase

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEURON SPECIFIC ENOLASE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BRAIN ISCHEMIA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 79955735131     PISSN: 09763147     EISSN: 09763155     Source Type: Journal    
DOI: 10.4103/0976-3147.80099     Document Type: Article

References (36)

1. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS. Prevalence of admission hyperglycemia across clinical subtypes of acute stroke. Lancet 1999;353:376-7. (Pubitemid 29088169)
2. Koistinaho J, Pasonen S, Yrjänheikki J, Chan P. Spreading depressioninduced gene expression is regulated by plasma glucose. Stroke 1999;30:114-9. (Pubitemid 29029451)
3. Wass CT, Lanier WL. Glucose modulation of ischemic brain injury: Review and clinical recommendations. Mayo Clin Proc 1996;71:801-12.
4. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independentpredictor of poor outcome after acute stroke? Results of a long-term follow up study. Br Med J 1997;314:1303-6. (Pubitemid 27183316)
5. Cunningham RT, Watt M, Winder J, McKinstry S, Lawson JT, Johnston CF, et al. Serum neurone-specifi c enolase as an indicator of stroke volume. Eur J Clin Invest 1996;26:298-303. (Pubitemid 26147065)
6. Missler U, Wiesmann M, Friedrich C, Kaps M. S-100 protein and neuronspecifi c enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic Stroke. Stroke. 1997;28:1956-60. (Pubitemid 27459003)
7. Persson L, Hårdemark HG, Gustafsson J, Rundström G, Mendel- Hartvig I, Esscher T, et al. S-100 protein and neuron-specifi c enolase in cerebrospinal fl uid and serum: Markers of cell damage in human central nervous system. Stroke 1987;18:911-8. (Pubitemid 17126635)
8. Schaarschmidt H, Prange HW, Reiber H. Neuron-specifi c enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases. Stroke 1994;25:558-65. (Pubitemid 24067066)
9. Ballantyne CM, Herd JA, Ferlic LL, Dunn JK, Farmer JA, Jones PH, et al. Infl uence of low HDL on progression of coronary artery disease and response to Fluvastatin therapy. Circulation 1999;99:736-43. (Pubitemid 29083012)
10. Miller GJ, Miller NE. Plasma high-density lipoprotein concentration and development of ischemic heart disease. Lancet 1975;1:16-20.
11. Yaari S, Goldbourt U, Even-Zohar S, Neufeld HN. Serum HDL and total cholesterol. Lancet 1981;1:1011-5.
12. Marangos PJ, Schmechel D, Parma AM, Clark RL, Goodwin FK. Measurement of neuron-specifi c enolase (NSE) and non-neuronal (NNE) isoenzymes of enolase in rat, monkey and human nervous tissue. J Neurochem 1979;33:319-29. (Pubitemid 9233939)
13. Kato K, Suzuki F, Umeda Y. Highly sensitive immunoassays for three forms of rat brain enolase. J Neurochem 1981;36:793-7. (Pubitemid 11100058)
14. Hårdemark HG, Ericsson N, Kotwica Z, Rundström G, Mendel-Hartvig I, Olsson Y, et al. S-100 protein and neuron-specifi c enolase in CSF after experimental traumatic or focal ischemic brain damage. J Neurosurg 1989;71:727-31. (Pubitemid 19275772)
15. Selakovic V, Raicevic R, Radenovic L. The increase of neuron-specifi c enolase in cerebrospinal fl uid and plasma as a marker of neuronal damage in patients with acute brain infarction. J Clin Neurosci 2005;12:542-7. (Pubitemid 41044195)
16. Cunningham RT, Watt M, Winder J, McKinstry S, Lawson JT, Johnston CF, et al. Serum neurone-specifi c enolase as an indicator of stroke volume. Eur J Clin Invest 1996;26:298-303. (Pubitemid 26147065)
17. Schaarschmidt H, Prange HW, Reiber H. Neuron-specifi c enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases. Stroke 1994;25:558-65. (Pubitemid 24067066)
18. Butterworth RJ, Wassif WS, Sherwood RA, Gerges A, Poyser KH, Garthwaite J, et al. Serum neuron-specifi c enolase, carnosinase, and their ratio in acute stroke. An enzymatic test for predicting outcome? Stroke 1996;27:2064-8. (Pubitemid 26372582)
19. Ishiguro Y, Kato K, Ito T, Nagaya M, Yamada N, Sugito T. Nervous system-specifi c enolase in serum as a marker for neuroblastoma. Pediatrics 1983;72:696-700. (Pubitemid 14232892)
20. Missler U, Wiesmann M, Friedrich C, Kaps M. S-100 protein and neuronspecifi c enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 1997;28:1956-60. (Pubitemid 27459003)
21. Stevens H, Jakobs C, de Jager AE, Cunningham RT, Korf J. Neuronespecifi c enolase and N-acetyl-aspartate as potential peripheral markers of ischaemic stroke. Eur J Clin Invest 1999;29:6-11. (Pubitemid 29084242)
22. Wunderlich MT, Ebert AD, Kratz T, Goertler M, Jost S, Herrmann M. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke 1999;30:1190-5. (Pubitemid 29259172)
23. Sulter G, Elting JW, De Keyser J. Increased serum neuron specifi c enolase concentrations in patients with hyperglycemic cortical ischemic stroke. Neurosci Lett 1998;253:71-3. (Pubitemid 28417022)
24. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. Br Med J 1997;314:1303-6. (Pubitemid 27183316)
25. Wass CT, Lanier WL. Glucose modulation of ischemic brain injury: Review and clinical recommendations. Mayo Clin Proc 1996;71:801-81.
26. Shahar E, Chambless LE, Rosamond WD, Boland LL, Ballantyne CM, McGovern PG, et al Plasma Lipid Profi le and Incident Ischemic Stroke: The Atherosclerosis Risk in Communities (ARIC) Study. Stroke 2003;34;623-31. (Pubitemid 36307382)
27. Johnson CJ, Kittner SJ, McCarter RJ, Sloan MA, Stern BJ, Buchholz D, et al. Interrater reliability of an etiologic classifi cation of ischemic stroke. Stroke 1995;26:46-51.
28. Papadakis JA, Mikhailidis DP, Winder AF. Lipids and stroke: Neglect of a useful preventive measure? Cardiovasc Res 1998;40:265-71. (Pubitemid 28506036)
29. Milionis HJ, Winder AF, Mikhailidis DP. Lp(a) and stroke. J ClinPathol 2000;53:487-96.
30. Palmer A, Bulpitt C, Beevers G, Coles E, Fletcher A, Ledingham J, et al. Risk factors for ischaemic heart disease and stroke mortality in young and old hypertensive patients. J Hum Hypertens 1995;9:695-7.
31. Demchuk AM, Hess DC, Brass LM, Yatsu FM. Is cholesterol a risk factor for stroke? Yes. Arch Neurol 1999;56:1518-20.
32. Ballantyne CM, Herd JA, Ferlic LL, Dunn JK, Farmer JA, Jones PH, et al. Infl uence of low HDL on progression of coronary artery disease and response to fl uvastatin therapy. Circulation 1999;99:736-43. (Pubitemid 29083012)
33. Gordon DJ, Probstfi eld JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, et al. High-density lipoprotein cholesterol and cardiovascular disease: Four prospective American studies. Circulation 1989;79:8-15. (Pubitemid 19043669)
34. Cuadrado-Godia E, Jiménez-Conde J, Ois A, Rodríguez- Campello A, García-Ramallo E, Roquer J. Sex differences in the prognostic value of the lipid profi le after the fi rst ischemic stroke. J Neurol. 2009;256:989-95.
35. Myers MG, Norris JW, Hachinski VC, Sole MJ. Plasma norepinephrine in stroke. Stroke 1981;12:200-4. (Pubitemid 11113179)
36. Willey JZ, Xu Q, Boden-Albala B, Paik MC, Moon YP, Sacco RL, et al. Lipid Profi le Components and Risk of Ischemic Stroke. Arch Neurol 2009;66:1400-6.